The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings

Overview of attention for article published in Multiple Sclerosis and Related Disorders, February 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 33,379 followers.

RT @ingentium_ms: The value of anti-JCV antibody index assessment in #MS #MultipleSclerosis patients treated with natalizumab with respect…

02 May 2019

Reply Repost Favourite

The value of anti-JCV antibody index assessment in #MS #MultipleSclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings. https://t.co/QTifs9tYgl

02 May 2019

Reply Repost Favourite

RT @POSTECTRIMS: The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to de…

25 Mar 2019

Reply Repost Favourite

RT @OhioHealthMS: The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to d…

22 Feb 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.